In September, the TNU research group and staff from the clinical HD team will participate in the conference on Huntington disease, EHDN & Enroll-HD 2024, in Strasbourg. The poster session will present the latest scientific findings in the HD field.

Åsa Petersén is responsible for the entire program and she is also a member of the EHDN Executive Committee.

At the EHDN and Enroll-HD 2024, the latest advances in basic, translational and clinical HD research will be presented.